脂质细胞在瘤治疗中的作用:双刃剑
Guo Wu1,2, Haotian Li3, Yixia Liang1,2
1Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.
Science China. Life sciences
|January 20, 2026
概括
经FDA批准的脂质体药物可以通过激活补体系统来损害癌症治疗. 这篇评论探讨了脂质体如何与免疫系统相互作用,以改善未来的癌症纳米医学.
科学领域:
- 纳米医学是一种纳米医学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 美国食品和药物管理局批准的脂质体药物提供了更好的毒性和输送.
- 新出现的证据表明,脂质体可以具有亲血管性和免疫抑制作用.
- 补充系统的激活与这些不良的脂质体效应有关.
研究的目的:
- 审查补充系统激活在脂质体药物不良影响中的作用.
- 分析脂质体,补充蛋白和瘤微环境之间的相互作用.
- 确定优化纳米载体设计的战略,以改善癌症纳米医学.
主要方法:
- 文献审查和现有证据的综合.
- 分析脂质体配方,补充蛋白和瘤微环境之间的动态相互作用.
- 阐明了潜在的脂质体-补充相互作用机制.
主要成果:
- 脂质体对补充剂的激活有助于产生亲血管性和免疫抑制作用.
- 这些影响可能会影响脂质体药物的治疗疗效.
- 了解这些相互作用对于优化脂质体药物设计至关重要.
结论:
- 下一代脂质体疗法需要设计以尽量减少免疫性潜力.
- 优化纳米载体设计可以提高效率并减少不良影响.
- 这一框架为转化癌症纳米药物开发提供了洞察力.
相关概念视频
Fixing Double-strand Breaks
14.3K
The double-stranded structure of DNA has two major advantages. First, it serves as a safe repository of genetic information where one strand serves as the back-up in case the other strand is damaged. Second, the double-helical structure can be wrapped around proteins called histones to form nucleosomes, which can then be tightly wound to form chromosomes. This way, DNA chains up to 2 inches long can be contained within microscopic structures in a cell. A double-stranded break not only damages...
14.3K
Fixing Double-strand Breaks
4.3K
4.3K
Double Resonance Techniques: Overview
719
Double resonance techniques in Nuclear Magnetic Resonance (NMR) spectroscopy involve the simultaneous application of two different frequencies or radiofrequency pulses to manipulate and observe two distinct nuclear spins. One important application of double resonance is spin decoupling, which selectively suppresses coupling with one type of nucleus while observing the NMR signal from another nucleus, simplifying the spectrum and enhancing resolution.
Spin decoupling is usually achieved by...
Spin decoupling is usually achieved by...
719
Parkinson's Disease: Treatment
1.0K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.0K
Alzheimer's Disease: Treatment
836
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
836
Open Angle Glaucoma: Treatment
969
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
969


